Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high‐risk acute myeloid leukaemia and other high risk myeloid malignancies

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|5|E97-E100

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.5, 2015-05, pp. : E97-E100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1048-1055

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I/II study of oral clofarabine plus low‐dose cytarabine in previously treated acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients at least 60 years of age

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 349-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 55-64

Karger

Access to resources Recommend Favorite

Post‐transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high‐risk acute myeloid leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 5, 2015-06 ,pp. : 756-759

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of a fludarabine and melphalan combination‐based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 883-889

John Wiley & Sons Inc

Access to resources Recommend Favorite